Back to Journals » OncoTargets and Therapy » Volume 10

Adverse renal effects of anaplastic lymphoma kinase inhibitors and the response to alectinib of an ALK+ lung cancer patient with renal dysfunction

Total article views   HTML views PDF downloads Totals
10,314 Dovepress* 9,157+ 1,174 10,331
PubMed Central* 1,157 286 1,443
Totals 10,314 1,460 11,774
*Since 29 June 2017
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 1 2

View citations on PubMed Central and Google Scholar